Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Cellectar Biosciences, Inc. (CLRB) had Current Liabilities of $9.39M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-44.58M |
|
-- |
|
-- |
|
$51.78M |
|
$-51.78M |
|
$7.26M |
|
$-44.52M |
|
$-58.31M |
|
$-44.58M |
|
$-44.58M |
|
$-44.58M |
|
$-58.36M |
|
$-51.78M |
|
$-51.49M |
|
36.62M |
|
37.14M |
|
$-1.22 |
|
$-1.40 |
|
| Balance Sheet Financials | |
$24.25M |
|
$0.76M |
|
$1.22M |
|
$25.47M |
|
|
Current Liabilities |
$9.39M |
-- |
|
$1.79M |
|
$11.18M |
|
$13.77M |
|
$14.29M |
|
$14.29M |
|
46.08M |
|
| Cash Flow Statement Financials | |
$-47.58M |
|
$-0.10M |
|
$61.41M |
|
$9.56M |
|
$23.29M |
|
$13.72M |
|
$4.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-323.67% |
|
-311.87% |
|
-175.01% |
|
-311.87% |
|
$0.31 |
|
$-1.28 |
|
$-1.28 |
|